Notice of Meeting; Moving Into the Future-New Dimensions and Strategies for Women's Health Research for the National Institutes of Health, 42312-42313 [E9-20149]
Download as PDF
42312
Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices
Dated: August 13, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–20152 Filed 8–20–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Meeting; Moving Into the
Future—New Dimensions and
Strategies for Women’s Health
Research for the National Institutes of
Health
Notice is hereby given that the Office
of Research on Women’s Health
(ORWH), Office of the Director, National
Institutes of Health, Department of
Health and Human Services, in
collaboration with Northwestern
University’s Feinberg School of
Medicine and Northwestern Memorial
Hospital, will convene a public hearing
and scientific workshop on October 14–
16, 2009, at Northwestern University,
Thorne Auditorium, Arthur Rubloff
Building, Chicago, Illinois.
srobinson on DSKHWCL6B1PROD with NOTICES
Purpose of the Meeting
With rapid advances in science and
wider global understanding of women’s
health and sex/gender contributions to
well-being and disease, the purpose of
the meeting is to ensure that NIH
continues to support cutting-edge
women’s health research that is based
upon the most advanced techniques and
methodologies. The meeting format is
designed to promote an interactive
discussion involving leading scientists,
advocacy groups, public policy experts,
health care providers, and the general
public. The Chicago meeting is the
fourth in a series that will be convened
throughout the Nation to help the
ORWH and NIH move into the next
decade of women’s health research.
As science and technology advance
and fields such as computational
biology demonstrate the power of
interdisciplinary research, it remains
critical for sex and gender factors to be
integrated into broad experimental
methodologies and scientific
approaches across the lifespan.
Biomedical and behavioral research are
also necessary to understand how
cultural, ethnic, and racial differences
influence the causes, diagnosis,
progression, treatment, and outcome of
disease among different populations,
including women of diverse geographic
locations and socioeconomic
backgrounds. Furthermore, the fact that
VerDate Nov<24>2008
16:22 Aug 20, 2009
Jkt 217001
there are health differences among
diverse populations of women remains
a critical area in need of continued
focus and attention.
The ORWH challenges all meeting
attendees to assist the NIH in defining
the women’s health research agenda of
the future by thinking beyond
traditional women’s health issues. The
ORWH and NIH ask meeting
participants to consider creative
strategies to identify areas of research
that are best poised for advancement,
identify innovative ways in which
persistent issues of health and disease
can be addressed, and explore new
horizons of scientific concepts and
investigative approaches. Attention also
needs to be paid to new areas of science
application, new technologies, and
continuing basic science investigations.
Clinical questions that are not currently
the focus of research priorities need to
be considered to ensure that women’s
health research is optimally served and
that the ORWH can continue to provide
leadership for the benefit of women’s
health, nationally and internationally.
Meeting Format
The meeting will consist of public
testimony, scientific panels and seven
concurrent scientific working groups.
Specifically, on October 14, individuals
representing a full spectrum of
organizations interested in biomedical
and behavioral research on women’s
health issues will have an opportunity
to provide public testimony from 2 to 6
p.m. On October 15 and 16, plenary
sessions will focus on the intersection of
health care, public policy, and
biomedical research; on emerging issues
and trends in health care; and on
research paradigms of the future. The
seven concurrent afternoon sessions on
October 15 will focus on a range of
research areas, including preventive
heath and special populations; clinical
trials/research; new technologies,
bioengineering, imaging; genetics/
epigenetics; sex hormones and disease;
neuroscience; and women in science
careers. On October 16, the morning
session will be devoted to reports by the
working group co-chairs regarding the
recommendations emerging from
working group deliberations on the
previous day. The meeting will adjourn
at 12:45 p.m. on October 16.
Public Testimony
The ORWH invites individuals with
an interest in research related to
women’s health to provide written and/
or oral testimony on these topics and/
or on issues related to the sustained
advancement of women in various
biomedical careers. Due to time
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
constraints, only one representative
from an organization or professional
specialty group may give oral testimony.
Individuals not representing an
organized entity but a personal point of
view are similarly invited to present
written and/or oral testimony. A letter
of intent to present oral testimony is
necessary and should be sent
electronically to https://
www.orwhmeetings.com/
movingintothefuture/ or by mail to Ms.
Jory Barone, Educational Services, Inc.,
4350 East-West Highway, Suite 1100,
Bethesda, MD 20814, no later than
October 4, 2009. The date of receipt of
the communication will establish the
order of those selected to give oral
testimony at the October meeting.
Those wishing to present oral
testimony are also asked to submit a
written form of their testimony that is
limited to a maximum of 10 pages,
double spaced, 12 point font, and
should include a brief description of the
organization. Electronic submission to
the above Web site is preferred;
however, for those who do not have
access to electronic means, written
testimony, bound by the restrictions
previously noted and postmarked no
later than October 4, 2009, can be
mailed to Ms. Jory Barone at the above
address. All written presentations must
meet the established page limitations.
Submissions exceeding this limit will
not be accepted and will be returned.
Oral testimony of this material at the
meeting will be limited to no more than
5–6 minutes in length.
Because of time constraints for oral
testimony, testifiers may not be able to
present the complete information as it is
contained in their written form
submitted for inclusion in the public
record for the meeting. Therefore,
testifiers are requested to summarize the
major points of emphasis from the
written testimony, not to exceed 6
minutes of oral testimony. Those
individuals or organizations that have
indicated they will present oral
testimony at the meeting in Chicago will
be notified prior to the meeting
regarding the approximate time for their
oral presentation.
Individuals and organizations wishing
to provide written statements only
should send a copy of their statements,
electronically or by mail, to the above
Web site or address by October 4, 2009.
Written testimony received by that date
will be made available at the October
14–16 meeting. Logistics questions
related to the meeting should be
addressed to Ms. Jory Barone at ESI,
while program-specific questions
should be addressed to Dr. Jody K.
Hirsch at the Feinberg School of
E:\FR\FM\21AUN1.SGM
21AUN1
Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 / Notices
Medicine, Chicago, Illinois, at telephone
number 312–503–3659 or e-mail address
jkhirsch@northwestern.edu.
At the conclusion of the regional
meetings, the ORWH will hold a
meeting at the NIH to summarize the
deliberations from the regional
conferences. The resulting report to the
ORWH and the NIH will ensure that
women’s health research in the coming
decade continues to support a vigorous
research agenda incorporating the latest
advances in technology and cuttingedge science.
Dated: August 13, 2009.
Raynard S. Kington,
Acting Director, National Institutes of Health.
[FR Doc. E9–20149 Filed 8–20–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
srobinson on DSKHWCL6B1PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Director’s
Consumer Liaison Group.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Director’s Consumer Liaison Group.
Date: October 20–22, 2009.
Time: October 20, 2009, 2 p.m. to 6 p.m.
Agenda: Welcome, Overview of the NCI
Advanced Therapeutics Platform, Expert
Panel on NCI Therapeutics Platform.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Time: October 21, 2009, 8:30 a.m. to 5:30
p.m.
Agenda: Gaining Community Input on NCI
Therapeutics Platform, Communicating with
the Community About the NCI Therapeutics
Platform, Advocates in Research Working
Group Discussion, NCI National Outreach
Network Discussion.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Time: October 22, 2009, 8:30 a.m. to 1 p.m.
Agenda: Communicating with the
Community about the NCI Therapeutics
Platform (cont’d), Engaging the Community
Around the NCI Therapeutics Platform,
Discussion with NCI Director.
VerDate Nov<24>2008
16:22 Aug 20, 2009
Jkt 217001
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Contact Person: Benjamin Carollo, MPA,
Advocacy Relations Manager, Office of
Advocacy Relations, Building 31, Room
10A30, 31 Center Drive, MSC 2580, National
Cancer Institute, NIH, DHHS, Bethesda, MD
20892–2580. 301–496–0307.
carollob@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:https://
deainfo.nci.nih.gov/advisory/dclg/dclg.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–20170 Filed 8–20–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Environmental
Health Sciences Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
42313
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Environmental Health Sciences Council.
Date: September 15–16, 2009.
Open: September 15, 2009, 8:30 a.m. to 5
p.m.
Agenda: Discussion of program policies
and issues.
Place: Nat. Inst. of Environmental Health
Sciences, Building 101, Rodbell Auditorium,
111 T. W. Alexander Drive, Research
Triangle Park, NC 27709.
Open: September 16, 2009, 8:30 a.m. to
10:30 a.m.
Agenda: Discussion of program policies
and issues.
Place: Nat. Inst. of Environmental Health
Sciences, Building 101, Rodbell Auditorium,
111 T. W. Alexander Drive, Research
Triangle Park, NC 27709.
Closed: September 16, 2009, 10:30 a.m. to
12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Nat. Inst. of Environmental Health
Sciences, Building 101, Rodbell Auditorium,
111 T. W. Alexander Drive, Research
Triangle Park, NC 27709.
Contact Person: Gwen W Collman, PHD,
Interim Director, Division of Extramural
Research & Training, National Institutes of
Health, Nat. Inst. of Environmental Health
Sciences, 615 Davis Dr., KEY615/3112,
Research Triangle Park, NC 27709, (919) 541–
4980, collman@niehs.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.niehs.nih.gov/dert/c-agenda.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
E:\FR\FM\21AUN1.SGM
21AUN1
Agencies
[Federal Register Volume 74, Number 161 (Friday, August 21, 2009)]
[Notices]
[Pages 42312-42313]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20149]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Meeting; Moving Into the Future--New Dimensions and
Strategies for Women's Health Research for the National Institutes of
Health
Notice is hereby given that the Office of Research on Women's
Health (ORWH), Office of the Director, National Institutes of Health,
Department of Health and Human Services, in collaboration with
Northwestern University's Feinberg School of Medicine and Northwestern
Memorial Hospital, will convene a public hearing and scientific
workshop on October 14-16, 2009, at Northwestern University, Thorne
Auditorium, Arthur Rubloff Building, Chicago, Illinois.
Purpose of the Meeting
With rapid advances in science and wider global understanding of
women's health and sex/gender contributions to well-being and disease,
the purpose of the meeting is to ensure that NIH continues to support
cutting-edge women's health research that is based upon the most
advanced techniques and methodologies. The meeting format is designed
to promote an interactive discussion involving leading scientists,
advocacy groups, public policy experts, health care providers, and the
general public. The Chicago meeting is the fourth in a series that will
be convened throughout the Nation to help the ORWH and NIH move into
the next decade of women's health research.
As science and technology advance and fields such as computational
biology demonstrate the power of interdisciplinary research, it remains
critical for sex and gender factors to be integrated into broad
experimental methodologies and scientific approaches across the
lifespan. Biomedical and behavioral research are also necessary to
understand how cultural, ethnic, and racial differences influence the
causes, diagnosis, progression, treatment, and outcome of disease among
different populations, including women of diverse geographic locations
and socioeconomic backgrounds. Furthermore, the fact that there are
health differences among diverse populations of women remains a
critical area in need of continued focus and attention.
The ORWH challenges all meeting attendees to assist the NIH in
defining the women's health research agenda of the future by thinking
beyond traditional women's health issues. The ORWH and NIH ask meeting
participants to consider creative strategies to identify areas of
research that are best poised for advancement, identify innovative ways
in which persistent issues of health and disease can be addressed, and
explore new horizons of scientific concepts and investigative
approaches. Attention also needs to be paid to new areas of science
application, new technologies, and continuing basic science
investigations. Clinical questions that are not currently the focus of
research priorities need to be considered to ensure that women's health
research is optimally served and that the ORWH can continue to provide
leadership for the benefit of women's health, nationally and
internationally.
Meeting Format
The meeting will consist of public testimony, scientific panels and
seven concurrent scientific working groups. Specifically, on October
14, individuals representing a full spectrum of organizations
interested in biomedical and behavioral research on women's health
issues will have an opportunity to provide public testimony from 2 to 6
p.m. On October 15 and 16, plenary sessions will focus on the
intersection of health care, public policy, and biomedical research; on
emerging issues and trends in health care; and on research paradigms of
the future. The seven concurrent afternoon sessions on October 15 will
focus on a range of research areas, including preventive heath and
special populations; clinical trials/research; new technologies,
bioengineering, imaging; genetics/epigenetics; sex hormones and
disease; neuroscience; and women in science careers. On October 16, the
morning session will be devoted to reports by the working group co-
chairs regarding the recommendations emerging from working group
deliberations on the previous day. The meeting will adjourn at 12:45
p.m. on October 16.
Public Testimony
The ORWH invites individuals with an interest in research related
to women's health to provide written and/or oral testimony on these
topics and/or on issues related to the sustained advancement of women
in various biomedical careers. Due to time constraints, only one
representative from an organization or professional specialty group may
give oral testimony. Individuals not representing an organized entity
but a personal point of view are similarly invited to present written
and/or oral testimony. A letter of intent to present oral testimony is
necessary and should be sent electronically to https://www.orwhmeetings.com/movingintothefuture/ or by mail to Ms. Jory
Barone, Educational Services, Inc., 4350 East-West Highway, Suite 1100,
Bethesda, MD 20814, no later than October 4, 2009. The date of receipt
of the communication will establish the order of those selected to give
oral testimony at the October meeting.
Those wishing to present oral testimony are also asked to submit a
written form of their testimony that is limited to a maximum of 10
pages, double spaced, 12 point font, and should include a brief
description of the organization. Electronic submission to the above Web
site is preferred; however, for those who do not have access to
electronic means, written testimony, bound by the restrictions
previously noted and postmarked no later than October 4, 2009, can be
mailed to Ms. Jory Barone at the above address. All written
presentations must meet the established page limitations. Submissions
exceeding this limit will not be accepted and will be returned. Oral
testimony of this material at the meeting will be limited to no more
than 5-6 minutes in length.
Because of time constraints for oral testimony, testifiers may not
be able to present the complete information as it is contained in their
written form submitted for inclusion in the public record for the
meeting. Therefore, testifiers are requested to summarize the major
points of emphasis from the written testimony, not to exceed 6 minutes
of oral testimony. Those individuals or organizations that have
indicated they will present oral testimony at the meeting in Chicago
will be notified prior to the meeting regarding the approximate time
for their oral presentation.
Individuals and organizations wishing to provide written statements
only should send a copy of their statements, electronically or by mail,
to the above Web site or address by October 4, 2009. Written testimony
received by that date will be made available at the October 14-16
meeting. Logistics questions related to the meeting should be addressed
to Ms. Jory Barone at ESI, while program-specific questions should be
addressed to Dr. Jody K. Hirsch at the Feinberg School of
[[Page 42313]]
Medicine, Chicago, Illinois, at telephone number 312-503-3659 or e-mail
address jkhirsch@northwestern.edu.
At the conclusion of the regional meetings, the ORWH will hold a
meeting at the NIH to summarize the deliberations from the regional
conferences. The resulting report to the ORWH and the NIH will ensure
that women's health research in the coming decade continues to support
a vigorous research agenda incorporating the latest advances in
technology and cutting-edge science.
Dated: August 13, 2009.
Raynard S. Kington,
Acting Director, National Institutes of Health.
[FR Doc. E9-20149 Filed 8-20-09; 8:45 am]
BILLING CODE 4140-01-P